What is MFine?
MFine operates as a sophisticated AI-driven, on-demand healthcare platform that bridges the gap between patients and top-tier medical institutions. Unlike traditional aggregators, the company partners directly with trusted hospitals to provide virtual consultations, connected care programs, and comprehensive health management services. By facilitating seamless access to remote diagnostics, medicine delivery, and routine lab testing, MFine has established itself as a critical player in the mHealth sector. The platform's architecture is designed to enhance patient outcomes by integrating clinical expertise with scalable technology, effectively transforming how routine and specialized care is accessed in a digital-first environment.
How much funding has MFine raised?
MFine has raised a total of $73.5M across 4 funding rounds:
Series A
$4.2M
Series B
$5.3M
Other Financing Round
$16M
Series C
$48M
Series A (2018): $4.2M, investors not publicly disclosed
Series B (2020): $5.3M led by Caretech Pte
Other Financing Round (2021): $16M supported by Alteria Capital, BEENEXT, Y'S Investment, SBI Ven Capital, SBI Investment Korea Co., and Heritas Capital Management Pte. Ltd.
Series C (2021): $48M featuring SBI Group Japan, Stellaris Venture Partners, Moore Strategic Ventures, and Beenext
Key Investors in MFine
Stellaris Venture Partners
Stellaris Venture Partners is an early-stage, technology-focused investment firm that is sector-agnostic. They are committed to supporting founders in building resilient businesses from the ideation stage to revenue milestones.
Beenext
BEENEXT is a founder-first venture capital firm that supports bold ideas from innovative entrepreneurs across various sectors, emphasizing collaboration and knowledge sharing.
SBI Ven Capital
SBI Ven Capital is a prominent private equity and private credit firm that focuses on investments in the financial services and technology sectors across Asia.
What's next for MFine?
With the recent infusion of capital, MFine is poised to scale its operational footprint and deepen its technological integration with hospital partners. The company's strategic roadmap likely involves expanding its service offerings to include more complex chronic disease management and enhancing its AI diagnostic capabilities to improve clinical accuracy. As the digital health market matures, MFine's focus on high-quality, hospital-backed virtual care provides a distinct competitive advantage. Future growth will likely center on increasing user acquisition, optimizing the supply chain for medicine delivery, and potentially exploring cross-border health tech collaborations to solidify its market leadership.
See full MFine company page
